Analysis of Staphylococcal Toxins and Clinical Outcomes of MRSA Bacteremia.

July 11, 2016 at 8:38 am

Biol Pharm Bull. 2016;39(7):1195-200.

Maeda M1, Shoji H, Shirakura T, Takuma T, Ugajin K, Fukuchi K, Niki Y, Ishino K.

Author information

1Division of Infection Control Sciences, Department of Pharmacotherapeutics, School of Pharmacy, Showa University.


It is well known that methicillin-resistant Staphylococcus aureus (MRSA) produces many virulence factors, such as hemolysins, leukocidins, proteases, enterotoxins, exfoliative toxins, and immune-modulatory factors. The aim of study was to identify staphylococcal pathogenicity that may affect the prognosis of patients with MRSA bacteremia. We obtained 149 MRSA strains from blood cultures between January 2009 and December 2014 in our institution. We collected information on patient characteristics, laboratory data, staphylococcal toxin genes, and susceptibility of the strain toward anti-MRSA agent and analyzed them as factors contributing to 30-d mortality. The “survival” and “dead” groups consisted of 103 and 46 patients, respectively. Multiple logistic regression analysis showed a four-fold increase in the risk of mortality in patients exhibiting isolated MRSA with staphylococcal enterotoxins (SEs) genes as well as toxic shock syndrome toxin-1 (TSST-1) genes [odds ratio: 3.89; 95% confidence interval: 1.20-12.60; p=0.024]. Kaplan-Meier analysis also showed significantly higher mortality in patient with isolated MRSA with SEs and TSST-1 genes. After adjusting for confounders, the coexistence of SEs and TSST-1 were independently associated with the 30-d mortality compared with treatment and susceptibility. The coexistence of superantigenic toxin genes greatly affects the clinical course and prognosis of patients with MRSA bacteremia.



Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Biología Molecular, Metodos diagnosticos, Resistencia bacteriana, Sepsis, Update.

A Program to Prevent Catheter-Associated Urinary Tract Infection in Acute Care. Association between Accessory Gene Regulator Polymorphism and Mortality among Critically Ill Patients Receiving Vancomycin for Nosocomial MRSA Bacteremia: A Cohort Study.


July 2016
« Jun   Aug »

Most Recent Posts

%d bloggers like this: